Bacterial and Viral Specimen Collection Market Size Analysis and Top Companies
The global bacterial and viral specimen collection market size is estimated to be worth around USD 151.41 billion by 2033 from USD 40.31 billion in 2023 with a CAGR of 14.15% from 2024 to 2033. The top companies operating in the bacterial and viral specimen collection market are Puritan Medical Products, COPAN Diagnostics, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Quidel Corporation, Longhorn Vaccines and Diagnostics, LLC, Pretium Packaging, Trinity Biotech, Medical Wire & Equipment, HiMedia Laboratories, Hardy Diagnostics, Nest Scientific, VIRCELL S.L., DiaSorin, Titan Biotech, and Others.
Market Report Coverage
| Report Coverage |
Details |
| Market Size by 2033 |
USD 151.41 Billion |
| Market Size in 2023 |
USD 40.31 Billion |
| Market Size in 2024 |
USD 46.01 Billion |
| Market Growth Rate from 2024 to 2033 |
CAGR of 14.15% |
| Largest Market |
North America |
| Base Year |
2023 |
| Forecast Period |
2024 to 2033 |
| Segments Covered |
Product, Application, End-use, and Regions |
| Regions Covered |
North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Bacterial and Viral Specimen Collection Key Players
- Puritan Medical Products
- COPAN Diagnostics
- Becton, Dickinson and Company
- Thermo Fisher Scientific, Inc.
- Quidel Corporation
- Longhorn Vaccines and Diagnostics, LLC
- Pretium Packaging
- Trinity Biotech
- Medical Wire & Equipment
- HiMedia Laboratories
- Hardy Diagnostics
- Nest Scientific
- VIRCELL S.L.
- DiaSorin
- Titan Biotech
Recent Developments
- On June 04, 2024, according to a study published in The Lancet, a Peer-reviewed journal and the European Health Union, European government faculty revealed that the 29-year-old Dutch scientist Rochelle Niemeijer innovated an affordable, fast, and artificial intelligence-driven tool to collect and diagnose bacterial infectious specimens. Up until July 9, 2024, the Dutch innovator will compete for the Young Inventors Prize, a recognition established by the European Patent Office, against a team from Tunisia and a finalist from Ukraine. Due to her promising work addressing one of the Sustainable Development Goals (SDGs) of the United Nations by making specimen collection and diagnosis more accessible, Niemeijer has been nominated as a finalist for the Young Inventors Prize of the European Inventor Award 2024.
- On January 19, 2024, ELITechGroup, an in-vitro diagnostics company, revealed the launch of the ‘GI Bacterial PLUS ELITe MGB Kit,’ which assists in bacterial specimen collection and diagnosis. The in vitro assay made available in ‘GI Bacterial PLUS ELITe MGB Kit’ is designed specifically to identify bacterial infections in the gastrointestinal tract. It targets key pathogens such as Yersinia enterocolitica, Clostridium difficile, Shigella species, Campylobacter species, and Salmonella species.
We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344
